(1RS,2R,3R,6R,7S,8S,9R,10R,12R)-7-[(2,6-dideoxy-3-[(2R,3R)-2,3-dihydroxypentan-2-yl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridecan-5-one (as per EP)
HSN Code :
Country of Origin :
Status :
Mol. Wt :
Synonyms :
Chemical Name :
38229010
India
Synthesis on demand
733.9
Pseudoerythromycin A Hemiketal (EP)
(1RS,2R,3R,6R,7S,8S,9R,10R,12R)-7-[(2,6-dideoxy-3-[(2R,3R)-2,3-dihydroxypentan-2-yl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridecan-5-one (as per EP)
+917744015207
info@medglowpharma.com | sales@medglowpharma.com
H.N. 1-1-111,Swapnaganda, Paras Nagar ,Nanded Maharastra, India -431602
Monday to Saturday 9am to 7pm
Services
API intermidates
Custom synthesis
API impurities
Working standards
Portfolio
Medglow Pharma Private Limited is a newly incorporated private company, registered under the Registrar of Companies (RoC), RoC-Delhi. It was registered with an authorized and paid-up capital of ₹1,00,000. The company falls under the class of Non-government companies. It was registered in 2025.
